AVITA Medical, Inc. (RCEL) Change in Cash (2019 - 2025)

AVITA Medical (RCEL) has reported Change in Cash for 7 consecutive years, with -$5.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash fell 12.86% year-over-year to -$5.2 million; the trailing twelve-month figure through Dec 2025 stood at -$3.8 million (up 52.81% YoY), and the FY2025 full-year result was -$3.8 million, up 52.81% from the prior year.
• Change in Cash fell to -$5.2 million in Q4 2025 per RCEL's latest filing, from $3.2 million in the prior quarter.
• Across five years, Change in Cash topped out at $55.1 million in Q1 2021 and bottomed at -$50.3 million in Q3 2021.
• Historically, Change in Cash has averaged $605000.0 across 5 years, with a median of $501000.0 in 2024.
• The sharpest annual moves came in 2021 and 2025: Change in Cash jumped 961.02% in 2021, then sank 629.74% in 2025.
• Over 5 years, Change in Cash stood at -$50.3 million in 2021, then surged by 88.76% to -$5.7 million in 2022, then plunged by 408.51% to -$28.7 million in 2023, then surged by 84.03% to -$4.6 million in 2024, then fell by 12.86% to -$5.2 million in 2025.
• According to Business Quant data, Change in Cash over the past three periods registered -$5.2 million, $3.2 million, and -$2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.